Skip to main content

Advertisement

Log in

The emerging nanomedicine landscape

  • Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

A global survey of companies pursuing 'nanomedicine' indicates that nanotechnology is taking root in the drug and medical device industry.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Nanomedicine publications and patents worldwide.
Figure 2: Sectorial and country breakdown of nanomedicine publications.
Figure 3: Sectorial and country breakdown of nanomedicine patent filings worldwide.

References

  1. European Science Foundation. Nanomedicine. An ESF–European Medical Research Councils (EMRC) Forward Look Report. (European Science Foundation, Strasbourg, 2005).

  2. European Science and Technology Observatory. Nanobiotechnology in the Medical Sector – Drivers for Development and Possible Impacts (Institute for Prospective Technological Studies, October 2006).

  3. Duncan, R. Nanomedicines in action. Pharm. J. 273, 485–488 (2004).

    Google Scholar 

  4. Royal Society & Royal Academy of Engineering. Nanoscience and Nanotechnologies: Opportunities and Uncertainties (Royal Society, London, 2004).

  5. Sato, M. & Webster, T.J. Nanobiotechnology: implications for the future of nanotechnology in orthopedic applications. Expert Rev. Med. Devices 1, 105–114 (2004).

    Article  CAS  Google Scholar 

  6. European Commission. Nanosciences and Nanotechnologies: An Action Plan for Europe 2005–2009 COM (European Commission, Brussels, 2005). http://cordis.europa.eu/nanotechnology/actionplan.

  7. Allen, T.M. & Cullis, P.R. Drug delivery systems: entering the mainstream. Science 303, 1818–1822 (2004).

    Article  CAS  Google Scholar 

  8. Duncan, R. Polymer therapeutics into the 21st Century, in Controlled Drug Delivery. ACS Symposium Series, vol. 752 (eds. Park, K. & Mrsny, R.J.) 350–363 (American Chemical Society, Washington, DC, 2000).

    Book  Google Scholar 

  9. Maurer, N., Fenske, D.B. & Cullis P.R. Developments in liposomal drug delivery systems. Expert Opin. Biol. Ther. 1, 923–947 (2001).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Data presented were largely derived from the European Science and Technology Observation network (ESTO) study Nanobiotechnology in the Medical Sector—Drivers for Development and Possible Impacts funded by the European Commission through ESTO. We are grateful to our anonymous interviewees who all gave generously of their time. We thank Yves Verbandt at the European Patent Office for the extensive analysis of the nanomedicine patent data. Thanks also to Jascha Knoche for preparing the figures.

Author information

Authors and Affiliations

Authors

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wagner, V., Dullaart, A., Bock, AK. et al. The emerging nanomedicine landscape. Nat Biotechnol 24, 1211–1217 (2006). https://doi.org/10.1038/nbt1006-1211

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1006-1211

  • Springer Nature America, Inc.

This article is cited by

Navigation